Kristen Oelschlager M.'s most recent trade in Castle Biosciences Inc was a trade of 18,007 Common Stock done at an average price of $21.7 . Disclosure was reported to the exchange on Aug. 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 21.69 per share. | 27 Aug 2025 | 18,007 | 153,793 (0%) | 0% | 21.7 | 390,572 | Common Stock |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 22.02 per share. | 27 Aug 2025 | 12,677 | 141,116 (0%) | 0% | 22.0 | 279,135 | Common Stock |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2025 | 10,640 | 174,604 (1%) | 0% | 0 | Common Stock | |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2025 | 10,640 | 0 | - | - | Performance-Based Stock Unit | |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.36 per share. | 08 Aug 2025 | 2,804 | 171,800 (1%) | 0% | 19.4 | 54,285 | Common Stock |
| Castle Biosciences Inc | Kristen Oelschlager M. | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 47,838 | 47,838 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Kristen Oelschlager M. | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 13,811 | 41,432 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Kristen Oelschlager M. | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 13,811 | 167,604 (0%) | 0% | - | Common Stock | |
| Castle Biosciences Inc | Kristen Oelschlager M. | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.23 per share. | 04 Mar 2025 | 3,640 | 163,964 (0%) | 0% | 22.2 | 80,917 | Common Stock |